| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC5A10 SLC9C2 SLC5A1 SLC5A4 MFSD2A SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 7.45e-16 | 171 | 150 | 18 | GO:0015081 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | SCN11A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.02e-15 | 26 | 150 | 10 | GO:0005248 |
| GeneOntologyMolecularFunction | sodium channel activity | SCN11A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 5.10e-12 | 52 | 150 | 10 | GO:0005272 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 SLC9C2 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 6.14e-12 | 465 | 150 | 22 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRE CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 ATP11B SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 4.02e-11 | 793 | 150 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRE CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 8.28e-11 | 758 | 150 | 26 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 SLC9C2 SLC36A2 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 3.16e-10 | 627 | 150 | 23 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 SLC9C2 SLC36A2 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 9.59e-10 | 664 | 150 | 23 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | GABRE VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 ABCB5 SLC7A6 SLC9C2 ABCA9 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 ATP11B SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GRAMD1C | 1.57e-09 | 1289 | 150 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRE CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 ABCB5 SLC7A6 SLC9C2 ABCA9 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 ATP11B SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 3.26e-09 | 1180 | 150 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium ion binding | 4.24e-08 | 14 | 150 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TAPT1 OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 GPR143 OR13G1 OR2J3 GPRC5A OR10T2 LPAR1 OR6A2 TAS2R16 OR8B12 CCR6 ADGRL2 OR4C5 ADGRL3 CXCR1 | 7.69e-07 | 884 | 150 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.30e-06 | 26 | 150 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC5A10 SLC7A6 SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 SLC24A2 SLC22A3 | 2.52e-06 | 296 | 150 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRE TAPT1 OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 MFSD6 GPR141 GPR143 OR13G1 OR2J3 GPRC5A OR10T2 LPAR1 OR6A2 TAS2R16 GLRB OR8B12 ROS1 CCR6 ADGRL2 OR4C5 ADGRL3 CXCR1 | 8.51e-06 | 1353 | 150 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRE CACNA1E SCN11A NALCN SLC24A2 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 9.81e-06 | 459 | 150 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1E SCN11A NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.13e-05 | 343 | 150 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.42e-05 | 7 | 150 | 3 | GO:0005412 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC5A10 ABCB5 SLC7A6 SLC9C2 ABCA9 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 SLC24A2 SLC22A3 | 1.51e-05 | 477 | 150 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC5A10 SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 MFSD2A SLC11A1 SLC41A3 SLC24A2 SLC22A3 | 1.77e-05 | 301 | 150 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | channel activity | GABRE CACNA1E SCN11A NALCN SLC24A2 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 4.32e-05 | 525 | 150 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRE CACNA1E SCN11A NALCN SLC24A2 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 4.41e-05 | 526 | 150 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | symporter activity | 1.41e-04 | 150 | 150 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | proteoglycan sulfotransferase activity | 1.67e-04 | 3 | 150 | 2 | GO:0050698 | |
| GeneOntologyMolecularFunction | amino acid binding | 2.23e-04 | 73 | 150 | 5 | GO:0016597 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.62e-04 | 17 | 150 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.62e-04 | 17 | 150 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.81e-04 | 119 | 150 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.01e-04 | 43 | 150 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | galactose 3-O-sulfotransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0050694 | |
| GeneOntologyMolecularFunction | galactosylceramide sulfotransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0001733 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.62e-04 | 81 | 150 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 OR8B12 OR4C5 | 4.23e-04 | 431 | 150 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | carboxylic acid binding | 4.58e-04 | 239 | 150 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 5.52e-04 | 5 | 150 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | antiporter activity | 6.19e-04 | 138 | 150 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | ankyrin binding | 6.59e-04 | 23 | 150 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | organic acid binding | 6.84e-04 | 254 | 150 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 8.24e-04 | 6 | 150 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 8.46e-04 | 25 | 150 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 8.46e-04 | 25 | 150 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.06e-03 | 27 | 150 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.32e-03 | 29 | 150 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | steroid binding | 3.33e-03 | 133 | 150 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 3.85e-03 | 42 | 150 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.14e-03 | 13 | 150 | 2 | GO:0050656 | |
| GeneOntologyMolecularFunction | myosin II binding | 4.14e-03 | 13 | 150 | 2 | GO:0045159 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 4.39e-03 | 44 | 150 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.81e-03 | 14 | 150 | 2 | GO:0140333 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A SLC5A10 SLC9C2 SLC5A1 SLC5A4 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.17e-12 | 208 | 148 | 16 | GO:0035725 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.15e-12 | 36 | 148 | 9 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SLC5A10 SLC9C2 SLC5A1 SLC5A4 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.46e-10 | 275 | 148 | 16 | GO:0006814 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.79e-10 | 62 | 148 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 6.72e-10 | 63 | 148 | 9 | GO:0019228 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | CACNA1E SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 8.07e-09 | 112 | 148 | 10 | GO:0019226 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRE VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 ATP11B SLC41A3 NALCN SLC24A2 SCN1A SLC22A3 SCN2A GLRB SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A GNAQ DNM2 | 9.48e-09 | 1374 | 148 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.26e-08 | 87 | 148 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRE VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.52e-08 | 1017 | 148 | 26 | GO:0098660 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.27e-08 | 93 | 148 | 9 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRE VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 ATP11B SLC41A3 NALCN SLC24A2 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.39e-08 | 1115 | 148 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | metal ion transport | VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC5A1 SLC5A4 SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A GNAQ DNM2 | 4.62e-08 | 1000 | 148 | 25 | GO:0030001 |
| GeneOntologyBiologicalProcess | actin filament-based movement | SCN11A MYO5C SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.59e-07 | 153 | 148 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC5A1 SLC5A4 SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.78e-07 | 922 | 148 | 23 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC5A1 SLC5A4 SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A GNAQ DNM2 | 1.96e-07 | 1157 | 148 | 26 | GO:0006812 |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.25e-07 | 121 | 148 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | action potential | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GNA11 GNAQ | 2.29e-07 | 201 | 148 | 11 | GO:0001508 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | VMP1 CACNA1E SCN11A SLC5A10 SLC39A1 SLC31A1 CBARP SLC9C2 SLC36A2 SLC5A1 SLC5A4 SLC11A1 SLC41A3 NALCN SLC24A2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.60e-07 | 942 | 148 | 23 | GO:0098655 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.41e-07 | 127 | 148 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | SCN11A TAPT1 OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 GPR143 OR13G1 OR2J3 GPRC5A OR10T2 LPAR1 OR6A2 TAS2R16 GLRB GNA11 OR8B12 CCR6 GNAQ ADGRL2 OR4C5 ADGRL3 DNM2 CXCR1 | 2.04e-06 | 1395 | 148 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRE SCN11A ABCB5 NALCN SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GNA11 GNAQ CNTF | 2.76e-06 | 559 | 148 | 16 | GO:0042391 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 3.06e-06 | 32 | 148 | 5 | GO:0048266 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.37e-06 | 167 | 148 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | detection of stimulus | SCN11A OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 SCN1A SCN9A SCN10A GNA11 OR8B12 GNAQ OR4C5 | 4.42e-06 | 722 | 148 | 18 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | SCN11A OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 SCN1A SCN9A SCN10A OR8B12 OR4C5 | 4.61e-06 | 582 | 148 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1E SCN11A CYP11B2 BCR SLC5A1 IFNB1 MFSD2A SCN1A SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GNA11 GNAQ | 5.44e-06 | 733 | 148 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1E SCN11A OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 GPR143 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 HMCN1 SCN1A GLRB SCN8A SCN9A SCN10A OR8B12 MARVELD2 OR4C5 | 8.27e-06 | 1072 | 148 | 22 | GO:0007600 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.77e-05 | 217 | 148 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | response to pain | 3.20e-05 | 51 | 148 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | heart contraction | CACNA1E SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 6.00e-05 | 298 | 148 | 10 | GO:0060047 |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1E SCN11A CYP11B2 BCR IFNB1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GNA11 GNAQ | 6.76e-05 | 648 | 148 | 15 | GO:0008015 |
| GeneOntologyBiologicalProcess | heart process | CACNA1E SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 8.11e-05 | 309 | 148 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 OR8B12 OR4C5 | 2.02e-04 | 485 | 148 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 2.53e-04 | 43 | 148 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 OR8B12 OR4C5 | 2.93e-04 | 432 | 148 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | intestinal D-glucose absorption | 3.04e-04 | 4 | 148 | 2 | GO:0001951 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 3.04e-04 | 4 | 148 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 OR8B12 OR4C5 | 4.08e-04 | 524 | 148 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | intestinal hexose absorption | 5.04e-04 | 5 | 148 | 2 | GO:0106001 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 5.04e-04 | 5 | 148 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 5.04e-04 | 5 | 148 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 OR8B12 OR4C5 | 5.44e-04 | 465 | 148 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 5.66e-04 | 142 | 148 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 5.66e-04 | 142 | 148 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 OR8B12 OR4C5 | 5.96e-04 | 547 | 148 | 12 | GO:0007606 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 6.53e-04 | 55 | 148 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 7.48e-04 | 57 | 148 | 4 | GO:0050974 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.61e-16 | 17 | 149 | 9 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.30e-13 | 29 | 149 | 9 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRE CACNA1E SCN11A STXBP5 NALCN SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 5.61e-07 | 378 | 149 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1E SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 7.43e-06 | 235 | 149 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | transporter complex | GABRE CACNA1E SCN11A STXBP5 ATP11B NALCN SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 9.49e-06 | 550 | 149 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | synaptic membrane | GABRE CACNA1E SCN11A STXBP5 LPAR1 TENM3 SCN1A SCN2A GLRB CLTC SCN8A SCN10A ADGRL2 ADGRL3 DNM2 | 1.88e-05 | 583 | 149 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRE CACNA1E SCN11A STXBP5 NALCN SCN1A SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.34e-05 | 523 | 149 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1E SCN11A STXBP5 LPAR1 TENM3 SCN1A SCN2A CLTC SCN8A SCN10A | 3.07e-05 | 277 | 149 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | axon | GAD1 SCN11A USP9X CBARP BCR TENM3 SCN1A LGI3 SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A ADGRL3 CNTF DNM2 | 6.66e-05 | 891 | 149 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | intercalated disc | 1.25e-04 | 68 | 149 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | presynapse | CACNA1E GAD1 SCN11A STXBP5 CBARP LPAR1 TENM3 SLC24A2 SCN1A LGI3 SLC22A3 SCN2A CLTC SCN8A SCN10A ATM DNM2 | 1.99e-04 | 886 | 149 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | C-fiber | 3.00e-04 | 4 | 149 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.70e-04 | 20 | 149 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRE CACNA1E SCN11A ANKFY1 STXBP5L STXBP5 PIGU SLC4A1 AP4E1 PIGH NALCN SCN1A SCN2A GLRB SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A GNA11 GNAQ | 3.89e-04 | 1498 | 149 | 23 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1E SCN11A STXBP5 SCN1A SCN2A GLRB SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A GNA11 GNAQ | 5.00e-04 | 785 | 149 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | cell-cell contact zone | 5.67e-04 | 94 | 149 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | axon initial segment | 1.13e-03 | 29 | 149 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | clathrin complex | 1.76e-03 | 9 | 149 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | T-tubule | 2.46e-03 | 79 | 149 | 4 | GO:0030315 | |
| HumanPheno | Allodynia | 1.38e-05 | 5 | 58 | 3 | HP:0012533 | |
| HumanPheno | Complex febrile seizure | 2.49e-05 | 16 | 58 | 4 | HP:0011172 | |
| MousePheno | abnormal action potential | 1.13e-05 | 133 | 112 | 8 | MP:0005402 | |
| Domain | Na_channel_asu | 1.02e-18 | 10 | 149 | 9 | IPR001696 | |
| Domain | Na_trans_assoc | 1.02e-18 | 10 | 149 | 9 | IPR010526 | |
| Domain | Na_trans_assoc | 1.02e-18 | 10 | 149 | 9 | PF06512 | |
| Domain | Channel_four-helix_dom | CACNA1E SCN11A SLC9C2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.20e-14 | 57 | 149 | 12 | IPR027359 |
| Domain | - | CACNA1E SCN11A SLC9C2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 2.20e-14 | 57 | 149 | 12 | 1.20.120.350 |
| Domain | Na_trans_cytopl | 2.33e-13 | 6 | 149 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 2.33e-13 | 6 | 149 | 6 | IPR024583 | |
| Domain | Ion_trans_dom | CACNA1E SCN11A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.83e-09 | 114 | 149 | 11 | IPR005821 |
| Domain | Ion_trans | CACNA1E SCN11A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 1.83e-09 | 114 | 149 | 11 | PF00520 |
| Domain | IQ_motif_EF-hand-BS | 4.19e-08 | 90 | 149 | 9 | IPR000048 | |
| Domain | IQ | 5.59e-08 | 93 | 149 | 9 | PS50096 | |
| Domain | IQ | 2.67e-07 | 81 | 149 | 8 | SM00015 | |
| Domain | IQ | 1.55e-06 | 71 | 149 | 7 | PF00612 | |
| Domain | ARM-type_fold | USP9X UBR4 NCBP1 HUWE1 LYST AP4E1 RIF1 CSE1L EIF2B5 CLTC ATM LRBA ARMH3 | 3.36e-06 | 339 | 149 | 13 | IPR016024 |
| Domain | Na/solute_symporter_CS | 2.71e-05 | 8 | 149 | 3 | IPR018212 | |
| Domain | Lgl_C | 6.32e-05 | 2 | 149 | 2 | PF08596 | |
| Domain | Lgl_C_dom | 6.32e-05 | 2 | 149 | 2 | IPR013905 | |
| Domain | 7tm_1 | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 OR13G1 OR2J3 OR10T2 LPAR1 OR6A2 OR8B12 CCR6 OR4C5 CXCR1 | 1.04e-04 | 677 | 149 | 16 | PF00001 |
| Domain | SSF | 1.04e-04 | 12 | 149 | 3 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 1.04e-04 | 12 | 149 | 3 | PS00457 | |
| Domain | Na/solute_symporter | 1.04e-04 | 12 | 149 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.04e-04 | 12 | 149 | 3 | PS50283 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 OR13G1 OR2J3 OR10T2 LPAR1 OR6A2 OR8B12 CCR6 OR4C5 CXCR1 | 1.19e-04 | 685 | 149 | 16 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 OR13G1 OR2J3 OR10T2 LPAR1 OR6A2 OR8B12 CCR6 OR4C5 CXCR1 | 1.31e-04 | 691 | 149 | 16 | PS50262 |
| Domain | GPCR_Rhodpsn | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 OR13G1 OR2J3 OR10T2 LPAR1 OR6A2 OR8B12 CCR6 OR4C5 CXCR1 | 1.33e-04 | 692 | 149 | 16 | IPR000276 |
| Domain | Latrophilin | 1.89e-04 | 3 | 149 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 1.89e-04 | 3 | 149 | 2 | IPR003334 | |
| Domain | GPCR_Rhodpsn_7TM | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 FPR3 GPR141 OR13G1 OR2J3 OR10T2 LPAR1 OR6A2 OR8B12 CCR6 CXCR1 | 3.07e-04 | 670 | 149 | 15 | IPR017452 |
| Domain | Olfact_rcpt | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 OR8B12 OR4C5 | 3.21e-04 | 393 | 149 | 11 | IPR000725 |
| Domain | LLGL | 3.75e-04 | 4 | 149 | 2 | PF08366 | |
| Domain | Gal-3-0_sulfotr | 3.75e-04 | 4 | 149 | 2 | PF06990 | |
| Domain | Lethal2_giant | 3.75e-04 | 4 | 149 | 2 | IPR000664 | |
| Domain | Gprotein_alpha_Q | 3.75e-04 | 4 | 149 | 2 | IPR000654 | |
| Domain | Gal-3-0_sulfotransfrase | 3.75e-04 | 4 | 149 | 2 | IPR009729 | |
| Domain | LLGL2 | 3.75e-04 | 4 | 149 | 2 | IPR013577 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.89e-04 | 46 | 149 | 4 | IPR011042 | |
| Domain | Gal_Lectin | 6.22e-04 | 5 | 149 | 2 | PF02140 | |
| Domain | GPCR_2_latrophilin | 6.22e-04 | 5 | 149 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 6.22e-04 | 5 | 149 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 6.22e-04 | 5 | 149 | 2 | PS50228 | |
| Domain | PH_BEACH | 9.29e-04 | 6 | 149 | 2 | PF14844 | |
| Domain | Haem_d1 | 9.29e-04 | 6 | 149 | 2 | IPR011048 | |
| Domain | ZnF_UBR1 | 1.29e-03 | 7 | 149 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.29e-03 | 7 | 149 | 2 | PS51157 | |
| Domain | zf-UBR | 1.29e-03 | 7 | 149 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.29e-03 | 7 | 149 | 2 | IPR003126 | |
| Domain | PyrdxlP-dep_de-COase | 1.72e-03 | 8 | 149 | 2 | IPR002129 | |
| Domain | PH-BEACH_dom | 1.72e-03 | 8 | 149 | 2 | IPR023362 | |
| Domain | - | 1.72e-03 | 8 | 149 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.72e-03 | 8 | 149 | 2 | PS51783 | |
| Domain | Pyridoxal_deC | 1.72e-03 | 8 | 149 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 1.72e-03 | 8 | 149 | 2 | PS00392 | |
| Domain | BEACH | 2.19e-03 | 9 | 149 | 2 | PS50197 | |
| Domain | Beach | 2.19e-03 | 9 | 149 | 2 | PF02138 | |
| Domain | - | 2.19e-03 | 9 | 149 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.19e-03 | 9 | 149 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.19e-03 | 9 | 149 | 2 | IPR000409 | |
| Domain | WD40_repeat_dom | 2.68e-03 | 297 | 149 | 8 | IPR017986 | |
| Domain | - | 2.70e-03 | 35 | 149 | 3 | 3.90.1150.10 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 2.93e-03 | 36 | 149 | 3 | IPR015422 | |
| Domain | NA_SOLUT_SYMP_1 | 3.32e-03 | 11 | 149 | 2 | PS00456 | |
| Domain | GAIN_dom_N | 3.32e-03 | 11 | 149 | 2 | IPR032471 | |
| Domain | GAIN | 3.32e-03 | 11 | 149 | 2 | PF16489 | |
| Domain | - | 3.69e-03 | 39 | 149 | 3 | 3.40.640.10 | |
| Domain | - | 3.69e-03 | 39 | 149 | 3 | 2.120.10.30 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.96e-03 | 12 | 149 | 2 | IPR011041 | |
| Domain | V_SNARE | 3.96e-03 | 12 | 149 | 2 | PS50892 | |
| Domain | PyrdxlP-dep_Trfase | 4.25e-03 | 41 | 149 | 3 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 4.25e-03 | 41 | 149 | 3 | IPR015421 | |
| Domain | OLF | 4.65e-03 | 13 | 149 | 2 | PF02191 | |
| Domain | OLF | 4.65e-03 | 13 | 149 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 4.65e-03 | 13 | 149 | 2 | IPR003112 | |
| Domain | OLF | 4.65e-03 | 13 | 149 | 2 | SM00284 | |
| Domain | Synaptobrevin | 4.65e-03 | 13 | 149 | 2 | IPR001388 | |
| Domain | - | 6.20e-03 | 15 | 149 | 2 | 1.25.40.180 | |
| Domain | MIF4-like | 6.20e-03 | 15 | 149 | 2 | IPR016021 | |
| Domain | GproteinA_insert | 7.05e-03 | 16 | 149 | 2 | IPR011025 | |
| Domain | - | 7.05e-03 | 16 | 149 | 2 | 1.10.400.10 | |
| Domain | G-alpha | 7.05e-03 | 16 | 149 | 2 | PF00503 | |
| Domain | G_alpha | 7.05e-03 | 16 | 149 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 7.95e-03 | 17 | 149 | 2 | IPR001019 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.02e-12 | 31 | 115 | 9 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.79e-12 | 32 | 115 | 9 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A CLTC SCN8A SCN9A SCN10A DNM2 | 3.95e-09 | 121 | 115 | 11 | M872 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.13e-06 | 130 | 115 | 9 | M27454 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GAD1 SCN11A ACACA SCN1A CSAD SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A GNAQ ADGRL3 | 1.69e-06 | 367 | 115 | 14 | M48346 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC5A10 SLC39A1 SLC31A1 SLC7A6 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 SLC24A2 SLC22A3 | 3.83e-06 | 238 | 115 | 11 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC5A10 SLC39A1 SLC31A1 SLC7A6 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 SLC24A2 SLC22A3 | 5.91e-06 | 249 | 115 | 11 | M5988 |
| Pathway | REACTOME_SENSORY_PERCEPTION | PLB1 OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 TAS2R16 SCN2A SCN3A SCN9A OR8B12 PLS1 OR4C5 | 1.51e-05 | 636 | 115 | 17 | M41834 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC5A10 SLC39A1 SLC31A1 ABCB5 PSMD3 SLC7A6 SLC9C2 ABCA9 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 ATP11B NALCN SLC24A2 SLC22A3 CLTC | 2.72e-05 | 736 | 115 | 18 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC5A10 SLC39A1 SLC31A1 ABCB5 PSMD3 SLC7A6 ABCA9 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 ATP11B NALCN SLC24A2 SLC22A3 CLTC | 3.60e-05 | 681 | 115 | 17 | MM14985 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.20e-05 | 203 | 115 | 9 | M5485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 4.29e-05 | 9 | 115 | 3 | M47732 | |
| Pathway | WP_DRAVET_SYNDROME | 7.40e-05 | 28 | 115 | 4 | M45519 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 4.66e-04 | 19 | 115 | 3 | MM14718 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 5.45e-04 | 20 | 115 | 3 | MM15077 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 5.72e-04 | 47 | 115 | 4 | M42524 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR7C2 OR4C6 OR6Q1 OR1S1 OR9Q1 OR13G1 OR2J3 OR10T2 OR6A2 OR8B12 OR4C5 | 5.99e-04 | 417 | 115 | 11 | M4072 |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 6.32e-04 | 21 | 115 | 3 | M27058 | |
| Pathway | WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN | 6.49e-04 | 5 | 115 | 2 | M48329 | |
| Pubmed | 4.30e-22 | 9 | 151 | 9 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.06e-15 | 6 | 151 | 6 | 23652591 | |
| Pubmed | 4.24e-14 | 13 | 151 | 7 | 15123669 | ||
| Pubmed | 5.04e-13 | 9 | 151 | 6 | 15746173 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.44e-12 | 5 | 151 | 5 | 22875929 | |
| Pubmed | 1.44e-12 | 5 | 151 | 5 | 17724025 | ||
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 17537961 | ||
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 35031483 | ||
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 29578003 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 3.41e-10 | 4 | 151 | 4 | 8974318 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.12e-09 | 12 | 151 | 5 | 30175250 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 8812438 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 16029194 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 23711479 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.09e-08 | 139 | 151 | 9 | 16985003 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.18e-08 | 7 | 151 | 4 | 24440715 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNHD1 SCN11A SLC5A10 ANKFY1 NCKAP1 PSMD3 HUWE1 GPRC5A BCR SLC36A2 SLC4A1 SLC5A1 CSE1L CLTC OSBPL1A SCN10A GNA11 GNAQ PLS1 DNM2 | 1.92e-08 | 1016 | 151 | 20 | 19056867 |
| Pubmed | 2.36e-08 | 8 | 151 | 4 | 25101983 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 4.23e-08 | 9 | 151 | 4 | 8854872 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 19284629 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 33895391 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 23859570 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 38999942 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 28784306 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 12610651 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 19699781 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18784617 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 17544618 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 32845893 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 20038812 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 28518218 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 17928448 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 8.02e-08 | 3 | 151 | 3 | 30554136 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 14973256 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 15302875 | ||
| Pubmed | 1.64e-07 | 12 | 151 | 4 | 8169823 | ||
| Pubmed | VMP1 USP9X UBR4 TM9SF3 NCBP1 HUWE1 SLC7A6 PIGU RIF1 RINT1 CSE1L EIF2B5 CLTC TMPO GPN3 | 2.01e-07 | 657 | 151 | 15 | 36180527 | |
| Pubmed | KNTC1 CACNA1E SCN11A MACC1 PCDHGC5 PCDHGB7 ABCB5 UBR4 TM9SF3 PSMD3 NCBP1 KRT79 LYST NEK2 RINT1 SCN4A CLTC SCN9A TMPO ATM MAPK6 PLS1 | 3.06e-07 | 1442 | 151 | 22 | 35575683 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 22260870 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 35801810 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 21156207 | ||
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 1679748 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 7.97e-07 | 5 | 151 | 3 | 37117223 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 24337656 | ||
| Pubmed | ANKFY1 ACACA NCKAP1 USP9X UBR4 PSMD3 NCBP1 HUWE1 RIF1 CSE1L CLTC TMPO LRBA DNM2 | 8.35e-07 | 638 | 151 | 14 | 33239621 | |
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.59e-06 | 6 | 151 | 3 | 17513486 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 9143501 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 2.77e-06 | 7 | 151 | 3 | 25818041 | |
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 15272007 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 23575686 | ||
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 9412493 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | USP9X SMCO1 TM9SF3 DOLK SLC7A6 PIGU LYST AP4E1 EIF2B5 SCN8A ARMH3 | 5.52e-06 | 457 | 151 | 11 | 32968282 |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 6.61e-06 | 9 | 151 | 3 | 17884088 | |
| Pubmed | 9.41e-06 | 10 | 151 | 3 | 38713721 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 9.96e-06 | 313 | 151 | 9 | 38270169 | |
| Pubmed | DENND5B CACNA1E ANKFY1 RALGAPB CBARP LINGO2 SLC4A1 SCN1A RTCA SCN9A | 1.20e-05 | 405 | 151 | 10 | 38187761 | |
| Pubmed | TOB2 ANKFY1 NCKAP1 STXBP5 RALGAPB VAT1L TENM3 MARK4 CLTC ADGRL3 | 1.25e-05 | 407 | 151 | 10 | 12693553 | |
| Pubmed | VMP1 TAPT1 STXBP5 PIGU LYST RINT1 OSBPL1A TMPO MARVELD2 LRBA ADGRL2 | 1.38e-05 | 504 | 151 | 11 | 34432599 | |
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 1.49e-05 | 71 | 151 | 5 | 8751373 | |
| Pubmed | Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). | 1.72e-05 | 12 | 151 | 3 | 10788617 | |
| Pubmed | A high-density association screen of 155 ion transport genes for involvement with common migraine. | 1.72e-05 | 12 | 151 | 3 | 18676988 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 1.87e-05 | 2 | 151 | 2 | 24642470 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 20346423 | ||
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 1.87e-05 | 2 | 151 | 2 | 28248732 | |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 1.87e-05 | 2 | 151 | 2 | 29970412 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.87e-05 | 2 | 151 | 2 | 37901435 | |
| Pubmed | Activation of Gq/11 in the mouse corpus luteum is required for parturition. | 1.87e-05 | 2 | 151 | 2 | 25495873 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.87e-05 | 2 | 151 | 2 | 26410685 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 24144460 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.87e-05 | 2 | 151 | 2 | 10827969 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19694741 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.87e-05 | 2 | 151 | 2 | 11245985 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15047701 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.87e-05 | 2 | 151 | 2 | 1317301 | |
| Pubmed | Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. | 1.87e-05 | 2 | 151 | 2 | 21945171 | |
| Pubmed | Lymphocyte-stromal cell interaction induces IL-7 expression by interferon regulatory factors. | 1.87e-05 | 2 | 151 | 2 | 23376291 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9175863 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.87e-05 | 2 | 151 | 2 | 23016767 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.87e-05 | 2 | 151 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.87e-05 | 2 | 151 | 2 | 25172946 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31439038 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28083870 | ||
| Pubmed | Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation. | 1.87e-05 | 2 | 151 | 2 | 26843449 | |
| Pubmed | Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. | 1.87e-05 | 2 | 151 | 2 | 30792275 | |
| Pubmed | Direct targeting of Gαq and Gα11 oncoproteins in cancer cells. | 1.87e-05 | 2 | 151 | 2 | 30890659 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28450535 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31943325 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 11834499 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9607776 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.87e-05 | 2 | 151 | 2 | 15249644 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 27690330 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31726051 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 11438569 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 37802294 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26628681 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 17552882 | ||
| Interaction | SCN11A interactions | 3.72e-12 | 15 | 138 | 7 | int:SCN11A | |
| Interaction | CACNA1D interactions | 1.12e-08 | 24 | 138 | 6 | int:CACNA1D | |
| Interaction | NALCN interactions | 2.67e-08 | 14 | 138 | 5 | int:NALCN | |
| Interaction | SCN5A interactions | 3.03e-08 | 47 | 138 | 7 | int:SCN5A | |
| Interaction | SCN1A interactions | 3.86e-08 | 29 | 138 | 6 | int:SCN1A | |
| Interaction | SCN9A interactions | 2.61e-07 | 21 | 138 | 5 | int:SCN9A | |
| Interaction | SCN10A interactions | 6.69e-07 | 11 | 138 | 4 | int:SCN10A | |
| Interaction | CACNA1B interactions | 5.12e-06 | 37 | 138 | 5 | int:CACNA1B | |
| Interaction | SCN8A interactions | 9.37e-06 | 20 | 138 | 4 | int:SCN8A | |
| Interaction | STX7 interactions | DENND5B VMP1 ANKFY1 SLC31A1 STXBP5 RALGAPB CBARP GPRC5A LPAR1 AP4E1 TMPO MARVELD2 LRBA MAPK6 ADGRL2 DEPDC1B | 1.18e-05 | 659 | 138 | 16 | int:STX7 |
| Interaction | SCN4B interactions | 1.72e-05 | 8 | 138 | 3 | int:SCN4B | |
| Interaction | RHOJ interactions | VMP1 USP9X TM9SF3 MFSD6 RALGAPB CBARP GPRC5A SLC7A6 CSE1L CLTC TMPO GNA11 MARVELD2 ADGRL2 DEPDC1B | 2.98e-05 | 633 | 138 | 15 | int:RHOJ |
| Interaction | MZB1 interactions | 6.61e-05 | 12 | 138 | 3 | int:MZB1 | |
| Interaction | ATP2C1 interactions | 6.87e-05 | 101 | 138 | 6 | int:ATP2C1 | |
| Cytoband | 15q21 | 5.80e-04 | 11 | 151 | 2 | 15q21 | |
| Cytoband | 2q24 | 5.80e-04 | 11 | 151 | 2 | 2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 8.49e-04 | 127 | 151 | 4 | chr2q24 | |
| Cytoband | 2q32 | 9.53e-04 | 14 | 151 | 2 | 2q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.03e-03 | 345 | 151 | 6 | chr11q12 | |
| Cytoband | 2q24.3 | 1.25e-03 | 16 | 151 | 2 | 2q24.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.18e-21 | 9 | 110 | 9 | 1203 | |
| GeneFamily | Solute carriers | SLC5A10 SLC39A1 SLC31A1 SLC7A6 SLC9C2 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 SLC41A3 SLC24A2 SLC22A3 | 8.28e-07 | 395 | 110 | 13 | 752 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 2.18e-04 | 4 | 110 | 2 | 918 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.55e-04 | 7 | 110 | 2 | 785 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TOB2 USP9X GAL3ST4 NCBP1 VAT1L HUWE1 LPAR1 RIF1 ZIK1 HMCN1 NALCN SCN1A GLRB SCN3A OSBPL1A TMPO COL14A1 GRAMD1C DEPDC1B ADGRL3 | 3.80e-07 | 836 | 136 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | DENND5B RBL1 GAL3ST4 CPA2 HUWE1 LPAR1 ABCA9 INTS10 ZIK1 HMCN1 SCN1A SCN2A GLRB SCN3A GNAQ ADGRL2 GRAMD1C DEPDC1B ADGRL3 | 1.21e-06 | 819 | 136 | 19 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | TOB2 GAL3ST4 NCBP1 HUWE1 RIF1 ZIK1 HMCN1 SCN1A GLRB OSBPL1A TMPO GRAMD1C DEPDC1B ADGRL3 | 3.44e-06 | 492 | 136 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TOB2 USP9X TM9SF3 GAL3ST4 VAT1L HUWE1 LPAR1 HHIP RIF1 ZIK1 NALCN SLC22A3 GLRB SCN3A COL14A1 DEPDC1B ADGRL3 | 1.94e-05 | 818 | 136 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.92e-05 | 196 | 136 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.43e-05 | 151 | 136 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | USP9X GAL3ST4 VAT1L HUWE1 RIF1 ZIK1 GLRB SCN3A COL14A1 DEPDC1B ADGRL3 | 1.02e-04 | 429 | 136 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | GAD1 GAL3ST4 NCBP1 VAT1L HUWE1 LPAR1 RIF1 ZIK1 HMCN1 GLRB SCN3A OSBPL1A TMPO COL14A1 DEPDC1B ADGRL3 | 1.11e-04 | 850 | 136 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CYP27C1 LINGO2 LYST ABCA9 MYO5C HMCN1 SCN2A SCN3A COL14A1 ADGRL2 | 9.12e-10 | 187 | 151 | 10 | 77886f99c229610abd28c4c370d2c7d1536c9782 |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 1.92e-07 | 180 | 151 | 8 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-07 | 186 | 151 | 8 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 187 | 151 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.67e-07 | 188 | 151 | 8 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-07 | 189 | 151 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.89e-07 | 190 | 151 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.01e-07 | 191 | 151 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-07 | 194 | 151 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-07 | 197 | 151 | 8 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-07 | 199 | 151 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-07 | 200 | 151 | 8 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.27e-07 | 200 | 151 | 8 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.27e-07 | 200 | 151 | 8 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-07 | 145 | 151 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.48e-06 | 177 | 151 | 7 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-06 | 182 | 151 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.09e-06 | 183 | 151 | 7 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.21e-06 | 184 | 151 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.21e-06 | 184 | 151 | 7 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.32e-06 | 185 | 151 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.44e-06 | 186 | 151 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 3.57e-06 | 187 | 151 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-06 | 189 | 151 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-06 | 189 | 151 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-06 | 191 | 151 | 7 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.10e-06 | 191 | 151 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.10e-06 | 191 | 151 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.24e-06 | 192 | 151 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.24e-06 | 192 | 151 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-06 | 195 | 151 | 7 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-06 | 195 | 151 | 7 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.86e-06 | 196 | 151 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.86e-06 | 196 | 151 | 7 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.02e-06 | 197 | 151 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.02e-06 | 197 | 151 | 7 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 198 | 151 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-06 | 198 | 151 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 199 | 151 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.37e-06 | 199 | 151 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 199 | 151 | 7 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 199 | 151 | 7 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.37e-06 | 199 | 151 | 7 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.55e-06 | 200 | 151 | 7 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 200 | 151 | 7 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.55e-06 | 200 | 151 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.55e-06 | 200 | 151 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 200 | 151 | 7 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-06 | 200 | 151 | 7 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-06 | 200 | 151 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.55e-06 | 200 | 151 | 7 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.85e-06 | 144 | 151 | 6 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-05 | 156 | 151 | 6 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-05 | 161 | 151 | 6 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-05 | 161 | 151 | 6 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-05 | 161 | 151 | 6 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 162 | 151 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 162 | 151 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 166 | 151 | 6 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 166 | 151 | 6 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 172 | 151 | 6 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 172 | 151 | 6 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 177 | 151 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.37e-05 | 179 | 151 | 6 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.37e-05 | 179 | 151 | 6 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.37e-05 | 179 | 151 | 6 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.37e-05 | 179 | 151 | 6 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.37e-05 | 179 | 151 | 6 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.48e-05 | 180 | 151 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.70e-05 | 182 | 151 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.81e-05 | 183 | 151 | 6 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 184 | 151 | 6 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.93e-05 | 184 | 151 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 184 | 151 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 184 | 151 | 6 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-05 | 185 | 151 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 4.05e-05 | 185 | 151 | 6 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 185 | 151 | 6 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.05e-05 | 185 | 151 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.17e-05 | 186 | 151 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 186 | 151 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 186 | 151 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.17e-05 | 186 | 151 | 6 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 187 | 151 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.30e-05 | 187 | 151 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 187 | 151 | 6 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 187 | 151 | 6 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 188 | 151 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 188 | 151 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 188 | 151 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 188 | 151 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 4.43e-05 | 188 | 151 | 6 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.43e-05 | 188 | 151 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 188 | 151 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 4.56e-05 | 189 | 151 | 6 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 190 | 151 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.98e-05 | 192 | 151 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| Drug | Zonisamide | 8.61e-12 | 17 | 150 | 7 | DB00909 | |
| Drug | Sodium | CACNA1E SCN11A CYP11B2 SLC4A1 SLC5A1 SCN2A SCN3A SCN5A SCN8A SCN9A SCN10A | 8.62e-12 | 84 | 150 | 11 | ctd:D012964 |
| Drug | APETx1, Anthopleura elegantissima | 6.93e-11 | 6 | 150 | 5 | ctd:C475726 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 6.40e-10 | 8 | 150 | 5 | ctd:C489827 | |
| Drug | cyfluthrin | 3.10e-08 | 29 | 150 | 6 | ctd:C052570 | |
| Drug | riluzole | GABRE CACNA1E IFNB1 GLRB SCN3A SCN4A SCN5A SCN9A SCN10A CNTF | 2.44e-07 | 174 | 150 | 10 | CID000005070 |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 2.80e-07 | 3 | 150 | 3 | ctd:C561228 | |
| Drug | decamethrin | 5.51e-07 | 146 | 150 | 9 | ctd:C017180 | |
| Drug | 1, 3-diallylurea | 5.82e-07 | 74 | 150 | 7 | CID000074537 | |
| Drug | AC1L1MOZ | 8.34e-07 | 27 | 150 | 5 | CID000031958 | |
| Drug | paraben | 1.01e-06 | 28 | 150 | 5 | CID000007175 | |
| Drug | sodium | GABRE SLC5A10 CYP11B2 HUWE1 SLC7A6 SLC36A2 SLC4A1 SLC5A1 SLC5A4 SLC11A1 ATP11B SLC24A2 SLC22A3 SCN2A SCN3A SCN4A SCN5A SCN9A SCN10A LRBA NR1H4 | 1.06e-06 | 944 | 150 | 21 | CID000000923 |
| Drug | Lidocaine | 1.12e-06 | 4 | 150 | 3 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.12e-06 | 4 | 150 | 3 | ctd:C501880 | |
| Drug | tocainide | 1.45e-06 | 30 | 150 | 5 | CID000038945 | |
| Drug | triamterene | 2.26e-06 | 58 | 150 | 6 | CID000005546 | |
| Drug | 5-hydroxypropafenone | 2.77e-06 | 34 | 150 | 5 | CID000107927 | |
| Drug | propafenone | 3.92e-06 | 98 | 150 | 7 | CID000004932 | |
| Drug | benzocaine | 4.27e-06 | 37 | 150 | 5 | CID000002337 | |
| Drug | saxitoxin | 4.43e-06 | 65 | 150 | 6 | CID000037165 | |
| Drug | AC1L1CQC | 4.43e-06 | 65 | 150 | 6 | CID000002012 | |
| Drug | mexiletine | 4.85e-06 | 66 | 150 | 6 | CID000004178 | |
| Drug | disopyramide | 4.85e-06 | 66 | 150 | 6 | CID000003114 | |
| Drug | Scorpion Venoms | 5.15e-06 | 18 | 150 | 4 | ctd:D012604 | |
| Drug | tetradotoxin | GABRE CACNA1E GAD1 SCN11A PSMD3 SCN2A GLRB SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 5.44e-06 | 428 | 150 | 13 | CID000020382 |
| Drug | fenpropathrin | 5.52e-06 | 6 | 150 | 3 | ctd:C044267 | |
| Drug | Tetrodotoxin | 6.34e-06 | 40 | 150 | 5 | ctd:D013779 | |
| Drug | diprafenone | 6.50e-06 | 19 | 150 | 4 | CID000071249 | |
| Drug | flecainide | 7.44e-06 | 71 | 150 | 6 | CID000003355 | |
| Drug | diphenhydramine | 1.02e-05 | 75 | 150 | 6 | CID000003100 | |
| Drug | lamotrigine | 1.20e-05 | 116 | 150 | 7 | CID000003878 | |
| Drug | pilsicainide | 1.28e-05 | 46 | 150 | 5 | CID000004820 | |
| Drug | spiradoline | 1.28e-05 | 46 | 150 | 5 | CID000005620 | |
| Drug | Cocaine | 1.53e-05 | 8 | 150 | 3 | DB00907 | |
| Drug | phenytoin | 1.54e-05 | 219 | 150 | 9 | CID000001775 | |
| Drug | AC1NT1AF | 2.06e-05 | 25 | 150 | 4 | CID005322157 | |
| Drug | Mexiletine | 2.29e-05 | 9 | 150 | 3 | ctd:D008801 | |
| Drug | Pirmenolum | 2.42e-05 | 26 | 150 | 4 | CID000004853 | |
| Drug | PbTx-1 | 2.82e-05 | 27 | 150 | 4 | CID006437089 | |
| Drug | nefopam | 2.82e-05 | 27 | 150 | 4 | CID000004450 | |
| Drug | potassium | CACNA1E CYP11B2 CPA2 SLC36A2 SLC4A1 BRAP SLC5A1 SLC11A1 ATP11B SLC24A2 SCN2A SCN3A SCN4A SCN5A CLTC SCN9A SCN10A GNAQ LRBA | 3.66e-05 | 1008 | 150 | 19 | CID000000813 |
| Drug | Hexylcaine | 4.31e-05 | 2 | 150 | 2 | DB00473 | |
| Drug | 6-fluorocholesterol | 4.31e-05 | 2 | 150 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 4.31e-05 | 2 | 150 | 2 | CID006454807 | |
| Drug | Ranolazine | 4.31e-05 | 2 | 150 | 2 | DB00243 | |
| Drug | Phenytoin | 4.31e-05 | 2 | 150 | 2 | DB00252 | |
| Drug | Flecainide | 4.31e-05 | 2 | 150 | 2 | DB01195 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 4.31e-05 | 2 | 150 | 2 | ctd:C502265 | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 7265_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1907_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 4173_UP | |
| Drug | NSC93767 | 5.64e-05 | 32 | 150 | 4 | CID000005658 | |
| Drug | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | 6.38e-05 | 33 | 150 | 4 | ctd:C498826 | |
| Drug | NSC15627 | 7.20e-05 | 34 | 150 | 4 | CID000002073 | |
| Drug | nitrosourea | 8.08e-05 | 35 | 150 | 4 | CID000105035 | |
| Drug | dibucaine | 8.66e-05 | 68 | 150 | 5 | CID000003025 | |
| Drug | GBR 12909 | 9.29e-05 | 69 | 150 | 5 | CID000003455 | |
| Drug | lidocaine | 9.42e-05 | 160 | 150 | 7 | CID000003676 | |
| Drug | amiodarone | 9.42e-05 | 160 | 150 | 7 | CID000002156 | |
| Drug | cysteic acid | 9.95e-05 | 70 | 150 | 5 | CID000025701 | |
| Drug | sipatrigine | 1.01e-04 | 37 | 150 | 4 | CID000060803 | |
| Drug | quindine | 1.05e-04 | 219 | 150 | 8 | CID000001065 | |
| Drug | aprindine | 1.12e-04 | 38 | 150 | 4 | CID000002218 | |
| Drug | Dibucaine | 1.29e-04 | 3 | 150 | 2 | DB00527 | |
| Drug | Dihydrocyclosporin C | 1.29e-04 | 3 | 150 | 2 | CID000196411 | |
| Drug | S-23 | 1.29e-04 | 3 | 150 | 2 | CID000151186 | |
| Drug | gabapentin | 1.32e-04 | 169 | 150 | 7 | CID000003446 | |
| Drug | S-ropivacaine | 1.38e-04 | 40 | 150 | 4 | CID000071273 | |
| Drug | hydrochlorothiazide | 1.46e-04 | 120 | 150 | 6 | CID000003639 | |
| Drug | cyclooctane | 1.78e-04 | 17 | 150 | 3 | CID000009266 | |
| Drug | bepridil | 1.90e-04 | 126 | 150 | 6 | CID000002351 | |
| Drug | NSC7524 | 2.09e-04 | 182 | 150 | 7 | CID000005657 | |
| Drug | moricizine | 2.13e-04 | 18 | 150 | 3 | CID000034632 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.29e-20 | 10 | 145 | 9 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.29e-20 | 10 | 145 | 9 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.82e-19 | 12 | 145 | 9 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1E GAD1 SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A | 5.56e-10 | 163 | 145 | 11 | DOID:1826 (implicated_via_orthology) |
| Disease | Primary Erythermalgia | 1.16e-07 | 3 | 145 | 3 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.16e-07 | 3 | 145 | 3 | C1833661 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.82e-06 | 22 | 145 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 4.01e-06 | 7 | 145 | 3 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.01e-06 | 7 | 145 | 3 | C0020075 | |
| Disease | Febrile Convulsions | 9.55e-06 | 9 | 145 | 3 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 9.55e-06 | 9 | 145 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.40e-05 | 2 | 145 | 2 | C4551549 | |
| Disease | Phakomatosis cesioflammea | 2.40e-05 | 2 | 145 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 2.40e-05 | 2 | 145 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 2.40e-05 | 2 | 145 | 2 | C1274879 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.21e-05 | 13 | 145 | 3 | C0751122 | |
| Disease | B Virus Infection | 7.17e-05 | 3 | 145 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 7.17e-05 | 3 | 145 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 7.17e-05 | 3 | 145 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.17e-05 | 3 | 145 | 2 | C0019372 | |
| Disease | Brugada ECG Pattern | 1.43e-04 | 4 | 145 | 2 | C1721096 | |
| Disease | Epilepsy | 2.07e-04 | 109 | 145 | 5 | C0014544 | |
| Disease | melanoma | 2.35e-04 | 248 | 145 | 7 | C0025202 | |
| Disease | Malignant melanoma of iris | 2.38e-04 | 5 | 145 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 2.38e-04 | 5 | 145 | 2 | C0346388 | |
| Disease | Familial benign neonatal epilepsy | 3.55e-04 | 6 | 145 | 2 | C0220669 | |
| Disease | Intellectual Disability | 3.83e-04 | 447 | 145 | 9 | C3714756 | |
| Disease | Seizure, Febrile, Simple | 4.96e-04 | 7 | 145 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.96e-04 | 7 | 145 | 2 | C0751057 | |
| Disease | electrocardiography, PR interval | 4.96e-04 | 7 | 145 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Profound Mental Retardation | 6.34e-04 | 139 | 145 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.34e-04 | 139 | 145 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.34e-04 | 139 | 145 | 5 | C0917816 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 6.59e-04 | 8 | 145 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 6.59e-04 | 8 | 145 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 6.59e-04 | 8 | 145 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 6.59e-04 | 8 | 145 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 6.59e-04 | 8 | 145 | 2 | C0438414 | |
| Disease | Uveal melanoma | 6.59e-04 | 8 | 145 | 2 | C0220633 | |
| Disease | Myoclonic Absence Epilepsy | 6.59e-04 | 8 | 145 | 2 | C0393703 | |
| Disease | QRS duration | 7.04e-04 | 298 | 145 | 7 | EFO_0005055 | |
| Disease | Myoclonic Epilepsy | 8.44e-04 | 9 | 145 | 2 | C0014550 | |
| Disease | supraventricular ectopy | 8.44e-04 | 9 | 145 | 2 | EFO_0009277 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.05e-03 | 10 | 145 | 2 | C0917800 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.05e-03 | 10 | 145 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | epilepsy | 1.08e-03 | 41 | 145 | 3 | EFO_0000474 | |
| Disease | Ischemic stroke | 1.14e-03 | 324 | 145 | 7 | HP_0002140 | |
| Disease | Neurodevelopmental Disorders | 1.16e-03 | 93 | 145 | 4 | C1535926 | |
| Disease | Myoclonic Astatic Epilepsy | 1.28e-03 | 11 | 145 | 2 | C0393702 | |
| Disease | Adenocarcinoma of large intestine | 1.31e-03 | 96 | 145 | 4 | C1319315 | |
| Disease | Familial dilated cardiomyopathy | 1.33e-03 | 44 | 145 | 3 | C0340427 | |
| Disease | Multiple Sclerosis | 1.42e-03 | 45 | 145 | 3 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 1.42e-03 | 45 | 145 | 3 | C0751324 | |
| Disease | Cardiomyopathy, Dilated | 1.71e-03 | 48 | 145 | 3 | C0007193 | |
| Disease | Rheumatoid Arthritis | 1.73e-03 | 174 | 145 | 5 | C0003873 | |
| Disease | Brugada Syndrome 1 | 1.81e-03 | 13 | 145 | 2 | C4551804 | |
| Disease | T wave morphology measurement | 2.10e-03 | 14 | 145 | 2 | EFO_0008398 | |
| Disease | platelet-to-lymphocyte ratio | 2.18e-03 | 363 | 145 | 7 | EFO_0008446 | |
| Disease | lymphocyte count | VMP1 MED30 ACACA PCDHGC5 PCDHGB7 RBL1 PSMD3 BCR LYST LPAR1 SLC4A1 MFSD2A MARK4 ATM GNAQ IL7 | 2.32e-03 | 1464 | 145 | 16 | EFO_0004587 |
| Disease | MMR-related febrile seizures | 2.41e-03 | 15 | 145 | 2 | EFO_0006519 | |
| Disease | P wave duration | 2.41e-03 | 15 | 145 | 2 | EFO_0005094 | |
| Disease | Necrosis | 2.53e-03 | 55 | 145 | 3 | C0027540 | |
| Disease | Neuralgia, Supraorbital | 2.75e-03 | 16 | 145 | 2 | C0038870 | |
| Disease | Neuralgia | 2.75e-03 | 16 | 145 | 2 | C0027796 | |
| Disease | Romano-Ward Syndrome | 2.75e-03 | 16 | 145 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 2.75e-03 | 16 | 145 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.75e-03 | 16 | 145 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.75e-03 | 16 | 145 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.75e-03 | 16 | 145 | 2 | C0423711 | |
| Disease | Drug-induced agranulocytosis | 2.75e-03 | 16 | 145 | 2 | HP_0012235 | |
| Disease | Paroxysmal Nerve Pain | 2.75e-03 | 16 | 145 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.75e-03 | 16 | 145 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.75e-03 | 16 | 145 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.75e-03 | 16 | 145 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.75e-03 | 16 | 145 | 2 | C0393706 | |
| Disease | lymphocyte:monocyte ratio | 3.08e-03 | 288 | 145 | 6 | EFO_0600088 | |
| Disease | colorectal cancer | 3.08e-03 | 604 | 145 | 9 | MONDO_0005575 | |
| Disease | Vitiligo | 3.11e-03 | 17 | 145 | 2 | C0042900 | |
| Disease | partial epilepsy | 3.11e-03 | 17 | 145 | 2 | EFO_0004263 | |
| Disease | immature granulocyte count | 3.11e-03 | 17 | 145 | 2 | EFO_0803542 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.48e-03 | 18 | 145 | 2 | HP_0002373 | |
| Disease | Ulcerative Colitis | 3.72e-03 | 63 | 145 | 3 | C0009324 | |
| Disease | Brugada syndrome | 3.88e-03 | 19 | 145 | 2 | MONDO_0015263 | |
| Disease | hip bone size | 4.06e-03 | 65 | 145 | 3 | EFO_0004844 | |
| Disease | sex interaction measurement, COVID-19 | 4.74e-03 | 21 | 145 | 2 | EFO_0008343, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIDEIYMLSVFDESI | 356 | Q4AC99 | |
| ILDNYVLLVVVMSLF | 41 | Q8N350 | |
| ITEIQEQLRDVMFYL | 526 | Q7Z569 | |
| ENYNVTLIVVMSIFV | 551 | Q8IYS0 | |
| TLQEIYANVTEMLLA | 336 | Q4G0S4 | |
| FEYMILATIIANCIV | 91 | Q15878 | |
| IMVLVDFFIQDTYTQ | 616 | P02730 | |
| SLEVMSQVQVLLYFL | 1236 | P11274 | |
| QIMDYIFSPEEIIFI | 1086 | Q8IUA7 | |
| DAEIYSMIFVILGVI | 731 | Q2M3G0 | |
| FLEGVQLYIMLVEVF | 946 | Q9HAR2 | |
| TDVYLLNMAIADILF | 81 | P51684 | |
| VEYLIKLLETESFQM | 591 | Q13085 | |
| EGVQLYLMLVEVFES | 931 | O95490 | |
| LFINEETIVMAYLFT | 1056 | O95490 | |
| IAYSIMIEDVQVLLD | 86 | P48052 | |
| QNTILEYVMINSIFE | 176 | Q5T2E6 | |
| EYVMINSIFEAILQI | 181 | Q5T2E6 | |
| LVTFLMDNYQEILKV | 381 | Q8WUY9 | |
| VLIDSVELAQQVLYM | 4241 | Q96M86 | |
| MESVYEALQTEIEFL | 231 | P0C7W6 | |
| EQYVLAIMNIVAKLF | 261 | Q9H324 | |
| AVQSYLTLLDMENVF | 491 | Q9UPM8 | |
| FYEDMIDIIQATIQQ | 346 | Q9ULI1 | |
| FSLVQDVIAIEYIVL | 141 | Q8NFJ5 | |
| INYMIVIFVIAVAVI | 181 | Q7Z602 | |
| ENVTSIMFLVALSEY | 221 | P50148 | |
| IMFLVALSEYDQVLV | 226 | P50148 | |
| VTNIDMLEEFAYLRT | 626 | Q9NVR2 | |
| MTQEEYALLTAIVIL | 391 | Q96RI1 | |
| AEMQFYLVVALALIS | 686 | Q9Y5F8 | |
| EDVVFLYLIEMDSQL | 231 | Q9P2R3 | |
| ITQMYFSIVFVVIDN | 111 | Q8NH92 | |
| INEVMVYVADITLAI | 191 | Q8NGZ3 | |
| ESYTQEVLIIMFAIF | 191 | Q8NGQ5 | |
| EVLEVLLIFVYLNMI | 166 | Q9UPQ8 | |
| YMVTLENLLFTAELD | 761 | Q09161 | |
| QYLDEEFVLRVMTQL | 106 | P51955 | |
| IVDALMEVTVYLQSD | 561 | P59045 | |
| INEMFQTFYISIVDL | 171 | Q9NZQ0 | |
| TLTQEIDFLQQLYEM | 271 | Q5XKE5 | |
| IDFLQQLYEMELSQV | 276 | Q5XKE5 | |
| VHVMIDINLFVSVYL | 101 | P25089 | |
| AIFNLVTFVVMVVLY | 211 | Q92633 | |
| YEIAPVFVLMEQITL | 216 | Q99259 | |
| VLMAFYQLEILAEET | 666 | Q13144 | |
| LADALVIFQLYEMIR | 421 | Q14651 | |
| LNSVYIVQEYMETDL | 101 | Q16659 | |
| TFDYELLQMLQIVVG | 521 | Q9Y5F6 | |
| LAFFIYVPMNEQIVI | 26 | Q9UM44 | |
| VDQLLYFEEQLLITM | 621 | Q8NG66 | |
| MTTYNVLFEILIEQI | 781 | P50851 | |
| LVENIDMDTSLILEY | 1436 | P50748 | |
| ISENKIVILLDYMFQ | 136 | Q7L985 | |
| SIMVLVCAINLYFVV | 471 | P49279 | |
| ILDMEYTIDIIFSQT | 111 | P78334 | |
| FASLVEYAVVQVMLN | 341 | P48167 | |
| MDVLASYSIFQELQL | 1 | O75840 | |
| VVVAVFLFLVYQAME | 421 | P42167 | |
| MYLFTLVENLAIILV | 36 | Q8NGQ2 | |
| MLVYDQQEVEAIFLV | 276 | Q6ZSS7 | |
| LVMLLLEYNADTTIV | 96 | Q9BXW6 | |
| DIEYQIKDMILQFIS | 151 | P50570 | |
| VMVAEYFDESLVLLA | 301 | Q96RP7 | |
| SDMQVVLAVLNLLYV | 126 | Q7Z6Z7 | |
| LIDYAELVFMITDAL | 76 | Q9H490 | |
| VQDIVYRTMEIFQLL | 41 | Q96HR3 | |
| YMTVLQSIENYVQID | 746 | Q9Y2A7 | |
| TSYFIVMVNNLLELD | 1741 | Q96RW7 | |
| YLTILVANVTIMAVI | 36 | Q8NGX3 | |
| LVALMESNLIITYAV | 386 | Q8NA29 | |
| SYMNELVVFIVVAVD | 191 | Q8NGG6 | |
| SLVMIAEYFDESLVL | 236 | Q96A11 | |
| TFIMLTYLNNTLVED | 1711 | Q13315 | |
| LQMEVERLIVQSYVL | 1551 | Q4G0P3 | |
| FNYSVMADIRELIEV | 46 | Q9UHW5 | |
| NLMSLTEYQIAVFAI | 411 | Q05707 | |
| VAAFAYQIEELMILL | 116 | P26441 | |
| IINESLLFYLEMQTD | 261 | P51810 | |
| ENVTSIMFLVALSEY | 221 | P29992 | |
| IMFLVALSEYDQVLV | 226 | P29992 | |
| AALTIYEMLQNIFAI | 76 | P01574 | |
| MLETETLNKYVVIIA | 31 | P25024 | |
| VFTCVLLEMQILLYS | 286 | Q6ZUT9 | |
| IDQAFVLARYLVEEM | 381 | Q9Y600 | |
| QYESVLMVSIDQLLD | 36 | P13232 | |
| GSQYFRVIEDLIVML | 2516 | Q99698 | |
| DTIQVKLIDLSQVMY | 331 | Q6ZN28 | |
| INVALFILYMAAAIV | 296 | Q8N4S9 | |
| TQLIIAYIMLAVEVR | 386 | Q96T53 | |
| LFEVIETEKTLYLVM | 121 | Q96L34 | |
| FLVETLTQEDIKMVY | 471 | P19099 | |
| TVLHIIQVVISYFLM | 136 | O15431 | |
| TLVNFEVENLAYMLV | 276 | Q9Y5Q0 | |
| ITMAFEIVYLVNSEL | 446 | O75751 | |
| SVSYQAVEILERFMV | 71 | Q8N815 | |
| SIAVLTQEIVVYLAM | 886 | P46019 | |
| DTFINNIVMYFVTIV | 191 | O60412 | |
| YVLVLTENTLIIMAI | 36 | O95222 | |
| LEVVIFVVVLIFYLM | 26 | O76001 | |
| VFTLIYFLTMVDNLI | 51 | Q8NGB2 | |
| YFLTMVDNLIIVVTI | 56 | Q8NGB2 | |
| SAVFLVMYVATVLEN | 26 | Q8NH72 | |
| VMYVATVLENLLIVV | 31 | Q8NH72 | |
| VYLAEFLMQLETFIA | 161 | Q5HYW3 | |
| MIIYVLESLTIIVQS | 11 | Q9NYV7 | |
| ALVTLVAENLATYME | 611 | Q93008 | |
| KVDILYNINMIFIII | 1381 | P35499 | |
| FLIVVNMYIAIILEN | 1586 | P35499 | |
| DVSFYIVDLIMLIIF | 241 | Q9UI40 | |
| ILYYKILETVMVQET | 466 | P28749 | |
| IIYIITVMVDCIDFS | 756 | Q5UIP0 | |
| ANISMLVSLVIIIQY | 231 | Q495M3 | |
| LIVVNMYIAIILENF | 1761 | Q14524 | |
| MYIAIILENFSVATE | 1766 | Q14524 | |
| ISFLVVVNMYIAVIL | 1746 | Q15858 | |
| VVNMYIAVILENFSV | 1751 | Q15858 | |
| AADISVIVIYFLVVM | 26 | Q9NY91 | |
| LIQVTILLYLAEVMV | 416 | Q96GZ6 | |
| VNLILAVVAMAYEEQ | 416 | Q9NY46 | |
| FVSYIIISFLVVVNM | 1751 | Q9NY46 | |
| IISFLVVVNMYIAVI | 1756 | Q9NY46 | |
| VVVNMYIAVILENFS | 1761 | Q9NY46 | |
| AFVNVVEVMELASLY | 1246 | Q6P1J6 | |
| AVLEMDYSIVDFLTL | 336 | Q5T5C0 | |
| ILDQIIDMTSYLLDL | 681 | Q96QV1 | |
| IVNIESFILSGYVIM | 181 | Q9Y2K9 | |
| FVSYIIISFLVVVNM | 1766 | P35498 | |
| IISFLVVVNMYIAVI | 1771 | P35498 | |
| VVVNMYIAVILENFS | 1776 | P35498 | |
| ITQIVDVFMEYNLIQ | 546 | Q00610 | |
| YFEVVTICDLIMILA | 76 | Q96FZ5 | |
| MNTFLIIYLVILISE | 286 | Q9Y2G3 | |
| VQEFIPYVFQVMSLL | 656 | P55060 | |
| PEVEAYLQLLVVIFM | 161 | O43242 | |
| YLFEVMQAVEQVILK | 31 | Q9H081 | |
| QMLVEKLDVYIYQEI | 676 | Q6NUQ1 | |
| AVIYTDALQTLIMVV | 191 | A0PJK1 | |
| FLVLVMEQITLAYKE | 121 | Q9NY26 | |
| MYIAVILENFNVATE | 1716 | Q9Y5Y9 | |
| LYLEVMLENFALVAS | 51 | Q3SY52 | |
| VDEYLQDQLIVFMAL | 291 | O00442 | |
| LINLILAVVAMAYEE | 416 | Q99250 | |
| FVSYIIISFLVVVNM | 1756 | Q99250 | |
| IISFLVVVNMYIAVI | 1761 | Q99250 | |
| VVVNMYIAVILENFS | 1766 | Q99250 | |
| YNTLIEEMLQVLIYI | 736 | Q8IWV7 | |
| EYIPFEALIMTLTQL | 321 | Q9HBJ7 | |
| DIVINEAIYMQKVIY | 121 | Q14442 | |
| FVSYIIISFLIVVNM | 1746 | Q9UQD0 | |
| IVVNMYIAIILENFS | 1756 | Q9UQD0 | |
| VIYYDINQIISTAVM | 2061 | Q9P273 | |
| LIEDLQPFSTYMIQI | 1516 | P08922 | |
| MELNILYSYVIEVLI | 71 | Q147U7 | |
| VTAYVMLFEVANLRE | 166 | Q9HCJ6 | |
| RYFVLDNSVILAMLE | 946 | Q86X10 | |
| DETLSNVEVFMQLIY | 71 | Q13296 | |
| LIVIIVAMIEDLYTE | 306 | Q9HD45 | |
| MALIYLIVEDVFQLI | 376 | Q92536 | |
| EVMLENYSILVSLGI | 41 | B4DU55 | |
| LINLTLAVVTMAYEE | 391 | Q9UI33 | |
| SFLIVVNMYIAVILE | 1591 | Q9UI33 | |
| EVPQMFILYVQVISL | 401 | Q5TAH2 | |
| QSVIKLYIIYNMLEV | 191 | Q6NXT6 | |
| AADISIIVIYFVVVM | 26 | P13866 | |
| DVFEAYTQLLTEMVL | 3151 | Q5T4S7 | |
| MQLEIKVALNFIISY | 1 | Q14106 | |
| LVVVMVCYFILSIIN | 371 | Q96GC9 | |
| MVVDSQLYVVVAQLF | 286 | Q8N145 | |
| AEYVFVIFMSIELNL | 921 | Q8IZF0 | |
| YIMLNLLVAIIVENF | 1436 | Q8IZF0 | |
| DVAIRIYHQFIIIME | 1491 | Q9NQX4 |